We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£92.15
This is the most expensive it has ever been. Walk away.
£92 today · previous high £92 · all-time low £92
Edward Elgar Publishing Intellectual Property, Pharmaceuticals & Public Health - Drug Access
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 53 days · 53 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 53 days • 1 price levels
Price Analysis
Most common price: £92 (53 days, 100.0%)
Price range: £92 - £92
Price levels: 1 different prices over 53 days
Description
Key Features
Analyses intellectual property rights impact on pharmaceutical access across developing countries using unified research methodology.
Covers nine developing nations including China and India alongside Canada to provide comparative perspective on drug market dynamics.
Examines regulatory framework changes and their effect on pharmaceutical sector development and medicine availability since 1970s.
Provides empirical evidence on trade and production paradigm shifts within the pharmaceutical industry and resulting health outcomes.
Addresses access to medicines as both a legal and public health issue for policymakers and healthcare stakeholders.
Product Specifications
- Brand
- Edward Elgar Publishing
- Format
- hardcover
- ASIN
- 1849800146
- Domain
- Amazon UK
- Release Date
- 30 November 2011
- Listed Since
- 19 April 2010
Barcode
No barcode data available
Similar Products You Might Like
Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World
Edward Elgar Publishing
Intellectual Property, Pharmaceuticals and Public Health: Access to Drugs in Developing Countries
Edward Elgar Publishing
Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens
Springer
Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World
Edward Elgar Publishing
Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective
Edward Elgar Publishing
Global Issues in Pharmaceutical Marketing
Routledge
A Human Rights Framework for Intellectual Property, Innovation and Access to Medicines
Routledge
Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)
Springer
Pharmaceuticals, Corporate Crime and Public Health
Edward Elgar Publishing
Pharmaceutical Industry and Public Policy in Post-reform India
Routledge
Balancing Wealth and Health - Intellectual Property & Medicine Access
Oxford University Press
Counterfeit and Falsified Medicines in the EU: A Legal Perspective (Elgar Studies in Health and the Law)
Edward Elgar Publishing
Innovation and Marketing in Pharma: Emerging Practices - Volume 20
Springer
Poor Quality Pharmaceuticals in Global Public Health: 5 (Trust, 5)
Springer
Pharmaceutical Public Policy
CRC Press
The Politics of Pharmaceutical Policy Reform: A Study of Generic Drug Regulation in Brazil: 26 (SpringerBriefs in Political Science, 26)
Springer
Global Pharmaceutical Policy
MACMILLAN
Wolters Kluwer Guide to EU and UK Pharmaceutical Law
Wolters Kluwer
World Pharmaceutical Industry
Cengage Learning